ML-289 |
A negative allosteric modulator of mGlu3 (IC50 = 0.66 µM) that displ… |
5 mg |
15195-5 |
More Info
|
ML-290 |
An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… |
1 mg |
21134-1 |
More Info
|
ML-290 |
An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… |
10 mg |
21134-10 |
More Info
|
ML-290 |
An RXFP1 agonist (EC50 = 0.094 µM for the human receptor in a cAMP p… |
5 mg |
21134-5 |
More Info
|
ML-291 |
A novel activator of the apoptotic arm of the UPR, but not the adaptive arm |
1 mg |
19831-1 |
More Info
|
ML-291 |
A novel activator of the apoptotic arm of the UPR, but not the adaptive arm |
10 mg |
19831-10 |
More Info
|
ML-291 |
A novel activator of the apoptotic arm of the UPR, but not the adaptive arm |
25 mg |
19831-25 |
More Info
|
ML-291 |
A novel activator of the apoptotic arm of the UPR, but not the adaptive arm |
5 mg |
19831-5 |
More Info
|
ML-297 |
A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… |
1 mg |
14792-1 |
More Info
|
ML-297 |
A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… |
10 mg |
14792-10 |
More Info
|
ML-297 |
A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… |
25 mg |
14792-25 |
More Info
|
ML-297 |
A selective GIRK1 / 2 activator (EC50s = 0.16 and 1.8 µM for GIRK1 /… |
5 mg |
14792-5 |
More Info
|
ML-298 |
A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… |
1 mg |
15349-1 |
More Info
|
ML-298 |
A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… |
10 mg |
15349-10 |
More Info
|
ML-298 |
A selective inhibitor of PLD2 (IC50 = 355 nM); decreases invasive migratio… |
5 mg |
15349-5 |
More Info
|
ML-299 |
A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… |
1 mg |
17632-1 |
More Info
|
ML-299 |
A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… |
5 mg |
17632-5 |
More Info
|
ML-299 |
A dual inhibitor of PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively); sel… |
500 µg |
17632-500 |
More Info
|
ML-311 |
An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… |
1 mg |
29445-1 |
More Info
|
ML-311 |
An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… |
10 mg |
29445-10 |
More Info
|
ML-311 |
An inhibitor of Mcl-1 (IC50 = 0.31 µM in a fluorescence polarization… |
5 mg |
29445-5 |
More Info
|
ML-314 |
An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… |
1 mg |
19550-1 |
More Info
|
ML-314 |
An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… |
10 mg |
19550-10 |
More Info
|
ML-314 |
An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… |
25 mg |
19550-25 |
More Info
|
ML-314 |
An NTS1 agonist; selective for NTS1 over NTS2 in a cell-based assay of rec… |
5 mg |
19550-5 |
More Info
|
ML-323 |
A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… |
10 mg |
18010-10 |
More Info
|
ML-323 |
A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… |
25 mg |
18010-25 |
More Info
|
ML-323 |
A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… |
5 mg |
18010-5 |
More Info
|
ML-323 |
A selective inhibitor of the USP1-UAF1 deubiquitinase complex activity (IC… |
50 mg |
18010-50 |
More Info
|
ML-324 |
A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… |
1 mg |
17472-1 |
More Info
|
ML-324 |
A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… |
10 mg |
17472-10 |
More Info
|
ML-324 |
A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… |
25 mg |
17472-25 |
More Info
|
ML-324 |
A cell-permeable inhibitor of JMJD2E (KDM4DL; IC50 = 920 nM); reduces the… |
5 mg |
17472-5 |
More Info
|
ML-329 |
An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… |
1 mg |
22481-1 |
More Info
|
ML-329 |
An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… |
10 mg |
22481-10 |
More Info
|
ML-329 |
An inhibitor of the MITF pathway (IC50 = 1.2 µM for TRPM-1 promoter… |
5 mg |
22481-5 |
More Info
|
ML-334 |
An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… |
1 mg |
31439-1 |
More Info
|
ML-334 |
An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… |
10 mg |
31439-10 |
More Info
|
ML-334 |
An inhibitor of the Nrf2-Keap1 protein-protein interaction; binds to the K… |
5 mg |
31439-5 |
More Info
|
ML-335 |
The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… |
1 mg |
15196-1 |
More Info
|
ML-335 |
The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… |
10 mg |
15196-10 |
More Info
|
ML-335 |
The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… |
25 mg |
15196-25 |
More Info
|
ML-335 |
The first identified agonist for OPRM1-OPRD1 heterodimerization (EC50 = 40… |
5 mg |
15196-5 |
More Info
|
ML-335 |
An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… |
10 mg |
27635-10 |
More Info
|
ML-335 |
An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… |
25 mg |
27635-25 |
More Info
|
ML-335 |
An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… |
5 mg |
27635-5 |
More Info
|
ML-335 |
An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2 (EC50s = 14.3 and 5.2 &… |
50 mg |
27635-50 |
More Info
|
ML-336 |
A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… |
1 mg |
9001920-1 |
More Info
|
ML-336 |
A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… |
10 mg |
9001920-10 |
More Info
|
ML-336 |
A quinazolinone-based compound that has been shown to inhibit a VEEV-induc… |
25 mg |
9001920-25 |
More Info
|